Trial Profile
Special Drug Use-results Surveillance for long term administration in adult (18 years and older) of CONCERTA, 18mg/ 27mg/ 36mg Tablets
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jun 2018
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Adverse reactions; Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 13 Jun 2018 Status changed from active, no longer recruiting to completed.
- 05 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 17 Dec 2014 New trial record